Coherus Oncology, Inc. short interest in 2022
In 2022, Coherus Oncology, Inc.'s disclosed short interest ran from 8.94% of shares outstanding on 14 Jan 2022 to 12.80% on 30 Dec 2022, a change of +3.86 percentage points. The year's high was 14.19% on 30 Jun 2022 and its low 8.51% on 31 Jan 2022, averaging 11.71% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.97 days on 30 Nov 2022. Full history: Coherus Oncology, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 8.94% (14 Jan 2022)
- End of year
- 12.80% (30 Dec 2022)
- Change
- +3.86 pp
- High
- 14.19% (30 Jun 2022)
- Low
- 8.51% (31 Jan 2022)
- Average
- 11.71%
- Highest days to cover
- 12.97 (30 Nov 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 8.94% | 7.69 | |
| 31 Jan 2022 | 8.51% | 6.73 | |
| 15 Feb 2022 | 9.69% | 7.31 | |
| 28 Feb 2022 | 9.19% | 7.06 | results (8-K), 10-K filed |
| 15 Mar 2022 | 9.07% | 11.27 | |
| 31 Mar 2022 | 9.88% | 8.72 | |
| 14 Apr 2022 | 9.90% | 10.46 | |
| 29 Apr 2022 | 11.25% | 10.54 | |
| 13 May 2022 | 13.06% | 7.65 | 10-Q filed, results (8-K) |
| 31 May 2022 | 13.16% | 8.96 | |
| 15 Jun 2022 | 12.56% | 10.87 | |
| 30 Jun 2022 | 14.19% | 8.48 | |
| 15 Jul 2022 | 12.72% | 10.53 | |
| 29 Jul 2022 | 13.67% | 10.80 | |
| 15 Aug 2022 | 13.39% | 7.19 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 12.24% | 11.09 | |
| 15 Sep 2022 | 12.10% | 7.07 | |
| 30 Sep 2022 | 12.37% | 9.10 | |
| 14 Oct 2022 | 11.96% | 10.50 | |
| 31 Oct 2022 | 11.98% | 10.50 | |
| 15 Nov 2022 | 12.83% | 7.32 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 13.02% | 12.97 | |
| 15 Dec 2022 | 12.45% | 11.64 | |
| 30 Dec 2022 | 12.80% | 4.77 |
See also: Coherus Oncology, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.